Suchergebnisse - "Shah, Nigam H"

PubPharm (11)

1

Health AI Assurance Laboratories-Reply

enthalten in: JAMA | 2024

von Shah, N. | Halamka, J. | Anderson, B.

CommentOn: JAMA. 2024 Mar 26;331(12):1061-1062. - PMID 38345804

2

Discrepancies Between Clearance Summaries and Marketing Materials of Software-Enabled Medical Devices Cleared by the US Food and Drug Administration

enthalten in: JAMA network open | 2023

von Shah, N. | Mello, M.

CommentOn: JAMA Netw Open. 2023 Jul 3;6(7):e2321792. - PMID 37405771

3

A Second Opinion From Observational Data on Second-line Diabetes Drugs

enthalten in: JAMA network open | 2018

von Callahan, A. | Shah, N.

CommentOn: JAMA Netw Open. 2018 Dec 7;1(8):e186125. - PMID 30646315

4

Pharmacovigilance Using Textual Data : The Need to Go Deeper and Wider into the Con(text)

enthalten in: Drug safety | 2017

von Sethi, T. | Shah, N.

CommentOn: Drug Saf. 2017 Nov;40(11):1075-1089. - PMID 28643174

5

Androgen Deprivation Therapy and Subsequent Dementia-Reply

enthalten in: JAMA oncology | 2017

von Nead, K. | Swisher-McClure, S. | Shah, N.

CommentOn: JAMA Oncol. 2017 Jan 1;3(1):49-55. - PMID 27737437

6

Research on Gun Violence vs Other Causes of Death

enthalten in: JAMA | 2017

von Stark, D. | Shah, N.

CommentOn: JAMA. 2017 Apr 4;317(13):1376-1377. - PMID 28384825

7

Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Nead, K. | Gaskin, G. | Chester, C. | +4

CommentOn: J Clin Oncol. 2016 Feb 20;34(6):566-71. - PMID 26644522

8

enthalten in: Gastroenterology | 2016

von Shah, N. | Cooke, J. | Leeper, N.

CommentOn: PLoS One. 2015;10(6):e0124653. - PMID 26061035

9

Comment on : "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance"

enthalten in: Drug safety | 2015

von Harpaz, R. | DuMouchel, W. | Shah, N.

CommentOn: Drug Saf. 2014 Sep;37(9):655-9. - PMID 25005708

10

Response to letters regarding article, "unexpected effect of proton pump inhibitors : elevation of the cardiovascular risk factor asymmetric dimethylarginine"

enthalten in: Circulation | 2014

von Ghebremariam, Y. | Lee, J. | LePendu, P. | +5

CommentOn: Circulation. 2013 Aug 20;128(8):845-53. - PMID 23825361